2015
DOI: 10.2147/jrlcr.s70351
|View full text |Cite
|
Sign up to set email alerts
|

mTOR signaling in the neuropathophysiology of depression: current evidence

Abstract: Despite significant progress in major depressive disorder (MDD) research over the past decades, the mechanisms underlying its pathophysiology and treatment remain to be established. The complexity and heterogeneity of MDD involves multiple causes, such as inflammation, genetic, and environmental factors that could be related to poor effectiveness, variability of response to antidepressant drugs, delay in clinical response, and side effects. Ketamine, an N-methyl-d-aspartate receptor antagonist, has been propos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 102 publications
(131 reference statements)
0
1
0
Order By: Relevance
“…The SNP of this gene (rs1109089) which has been re-tested and found significant in the present study, has already been implicated in suicide [ 36 ]. mTOR pathway is well known for its antidepressant drug response [ 37 39 ]. Emerging quick and effective antidepressants are now available based on RHEB mediated mTOR pathway which is showing an effect on treatment-resistant subjects [ 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…The SNP of this gene (rs1109089) which has been re-tested and found significant in the present study, has already been implicated in suicide [ 36 ]. mTOR pathway is well known for its antidepressant drug response [ 37 39 ]. Emerging quick and effective antidepressants are now available based on RHEB mediated mTOR pathway which is showing an effect on treatment-resistant subjects [ 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%